The article cites a recent interview with Sandoz CEO, Richard Saynor, who claims that Novo Nordisk never filed a patent for Ozempic, the blockbuster weight-loss drug, in Canada
Originating as a treatment for type 2 diabetes, Semaglutide was approved by the FDA for chronic weight management in 2021, following rigorous trials that demonstrated its safety and efficacy
You can not be treated with semaglutide or Tirzepatide if you have: Medullary thyroid cancer Multiple endocrine neoplasia Type 1 diabetics Type 2 diabetics already taking a GLP-1 medication History of pancreatitis Chronic kidney disease (unless cleared by nephrologist) Nursing, pregnant, or trying to get pregnant Short moments of nausea, Constipation or diarrhea Fatigue Takes away desire for alcohol Yes, unlike vaccines or many other shots you may think of, this injection is done with a tiny needle that only goes under the skin, not into muscle
The recommended range for researchers on GLP-1 medications is 1.6-2.2 grams per kilogram of body weight daily
Also read about urine sugar level What are the Guidelines for Using ICD-11 Codes For Diabetes Structured as an Alphanumeric Code with a Letter in the second position and Number in the third character position
